Revelation Biosciences, Inc. reminded shareholders to cast their votes for the upcoming Special Meeting of Stockholders scheduled for January 17, 2025. A key proposal, Proposal 2, involves the redomicile of the company from Delaware to Nevada. This strategic move is projected to save the company at least $200,000 per year in franchise tax fees.
The Board of Directors has recommended a vote in favor of all proposals presented in the proxy statement. Shareholders were encouraged to vote by contacting Advantage Proxy. The special meeting was planned to take place virtually via a Zoom videoconference, with telephone participation options also available.
This initiative underscores the company's efforts to optimize its operational expenses and enhance its financial efficiency. For a clinical-stage life sciences company, reducing recurring costs can contribute to extending its cash runway and supporting its ongoing research and development programs.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.